| Code | Description | Claims | Beneficiaries | Total Paid |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
5,459 |
3,462 |
$476K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,220 |
1,718 |
$93K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,064 |
681 |
$78K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,601 |
1,038 |
$71K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
803 |
498 |
$58K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,025 |
651 |
$47K |
| 99385 |
|
480 |
320 |
$43K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,562 |
1,211 |
$39K |
| 99384 |
|
252 |
161 |
$23K |
| 99386 |
|
232 |
156 |
$22K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
338 |
263 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
199 |
131 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
415 |
303 |
$15K |
| 99383 |
|
173 |
99 |
$14K |
| 99223 |
Prolong inpt eval add15 m |
196 |
189 |
$14K |
| A4927 |
Gloves, non-sterile, per 100 |
681 |
522 |
$4K |
| 99222 |
Initial hospital care, per day, moderate complexity |
61 |
54 |
$4K |
| 99382 |
|
32 |
17 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
50 |
31 |
$2K |
| 99072 |
|
264 |
167 |
$775.00 |
| 92611 |
|
13 |
13 |
$714.35 |
| A9270 |
Non-covered item or service |
296 |
236 |
$0.00 |
| S5175 |
Laundry service, external, professional; per order |
294 |
235 |
$0.00 |
| E0700 |
Safety equipment, device or accessory, any type |
297 |
237 |
$0.00 |
| A4245 |
Alcohol wipes, per box |
297 |
237 |
$0.00 |
| A4928 |
Surgical mask, per 20 |
297 |
237 |
$0.00 |
| A4618 |
Breathing circuits |
17 |
17 |
$0.00 |